ImmunoMedicine
Wiley · United States
Aims & Scope✦ Inferred from recent articles
ImmunoMedicine publishes research on immunology and immunotherapy for various diseases, including cancer, autoimmune disorders, neurological conditions, and chronic inflammatory diseases. Key areas of interest include checkpoint inhibitors, adoptive cell therapy, cytokine therapies, transplantation, and vaccination. The journal also focuses on clinical trials, personalized immunotherapies, and biomarkers for targeted therapies.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about ImmunoMedicine
Is ImmunoMedicine a predatory journal?
PubScope has no integrity flags on record for ImmunoMedicine: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of ImmunoMedicine?
ImmunoMedicine is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is ImmunoMedicine indexed in Scopus and Web of Science?
ImmunoMedicine is indexed in DOAJ.
How much does it cost to publish in ImmunoMedicine?
ImmunoMedicine charges an article processing charge (APC) of about €2,410 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref